Company ProfilePremium

P2i Ltd.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
P2i Ltd. - Company showcase

Year Founded & Workforce

2004

203 Employees

P2i Ltd. logo

P2i Ltd. Employee Contacts

5 verified contactsNames, job titles, seniority and locations

View Employee Contacts

P2i Ltd. Overview

P2i is a UK deep-tech surface-engineering company spun out of the UK Ministry of Defence's Defence Science and Technology Laboratory in 2004. It applies molecular-scale protective coatings, nanometres thick, to finished electronic devices and printed-circuit-board assemblies, making them resistant to water and other liquids. The original technology is a patented pulsed plasma-enhanced chemical vapour deposition (PECVD) process. Since 2025 it has been complemented by a liquid-applied barrier coating line (LBC) that drops into existing spray and dip lines. P2i sells primarily to OEMs and contract manufacturers in consumer electronics, hearing aids and medical devices, automotive and industrial IoT. It typically deploys coating equipment "factory-in-factory" inside customer plants in Asia. P2i positions itself as the only vendor offering both plasma and liquid barrier protection at OEM scale, with PFAS-free, solvent-free and fully reworkable chemistries aligned to tightening EU regulation. Since September 2025 it has been controlled by Jolt Capital.


Company's own description

P2i's current website describes the business as applying molecular-level protective coatings to electronics at OEM scale, using plasma, liquid, or both. It claims more than ten billion devices protected, over 20 years in production electronics, and more than 100 million hearing aids protected. It frames itself as an end-to-end engineering partner that reviews a customer's device, manufacturing process and reliability requirements, recommends a protection path, and then delivers it through "factory-in-factory" deployment wherever the customer manufactures (p2i.com homepage and About page, 2026). The statutory strategic report from the latest annual accounts (FY2024) could not be retrieved.

What the company does

Core technology: The pulsed-plasma PECVD process deposits an ultra-thin polymer film onto every internal and external surface of an assembled device. The film is covalently bonded to the surface and lowers surface energy, so liquids bead up and roll off. Coatings are roughly 1/1000th the thickness of a human hair (P2i press release, Jan 2014; Physics World, Jun 2014; Dealroom profile).

Protection tiers: - Splash-proof (hydrophobic; historically IPX1–2 class).

  • Barrier coatings (IPX3–IPX8 class; historically branded Dunkable®).

  • Liquid Barrier Coatings (LBC), launched 2025, applied by spray, dip or jet with no vacuum and no cure cycle, and rated IPX3 to IPX8 (Dealroom; P2i 2025 review).

Value proposition claimed: No mechanical seals or gaskets needed; no change to device form factor or acoustic performance; reduced or eliminated masking; 100% reworkability, which supports right-to-repair; PFAS-free options across the portfolio (p2i.com 2026).

Business and revenue model

P2i has historically used flexible models (Dealroom; Caplight; legacy website):

  1. Equipment deployed in customer factories ("factory-in-factory"), with P2i-owned or customer-acquired plasma chambers installed on OEM or EMS production lines. P2i has publicly shown chambers of up to 2,000 litres that can coat about 600 phones per cycle (TechRadar).

  2. Coating-as-a-service / per-unit processing, charged on a per-device or per-batch basis, either at P2i facilities or at customer sites.

  3. Licensing / technology fees, which are referenced by aggregators (startups.one.gob.es / Dealroom) but not quantified.

  4. Consumables and engineering services, including sampling, qualification, NPI support and continuous on-site support through the product lifecycle (legacy company overview).

The product / service / licensing mix is not publicly disclosed. The FY2022 gross margin of 68.1% (Craft.co, from filed accounts) suggests a business weighted toward per-unit coating fees and IP-rich services rather than pure hardware sales.

Value-chain position

P2i sits between specialty-chemical / coating-material suppliers and electronics OEMs and their contract manufacturers. It is a process-technology and service provider embedded in the customer's final-assembly or PCBA stage. In effect, it competes with parylene coaters, traditional liquid conformal coatings (acrylic, silicone, urethane) and mechanical sealing (gaskets, membranes).

Customer types and end-markets

End-market (company-defined, 2026 website)Typical customersDisclosed reference customers / evidence
Consumer electronicsSmartphone, earphone and wearable OEMs and their EMS partnersMotorola, Alcatel One Touch, Huawei (Ascend D2), reported Nokia collaboration (2013); unnamed wireless-earphone customer that replaced parylene at scale (GSMArena 2013; Tudor Brown appointment release 2013; p2i.com 2026)
Medical devices / hearing aidsHearing-aid OEMsSiemens, GN ReSound (2013 release); more than 5 million hearing aids coated by 2013; more than 100 million by 2026 (Nanalyze 2013; p2i.com)
AutomotiveTier-1 electronics, PCBANamed customers not disclosed; positioned as PCBA protection for harsh environments (p2i.com)
Industrial IoTRuggedised field devicesNamed customers not disclosed
Legacy: lifestyle / textiles / footwear (ion-mask)Footwear brandsTimberland, Teva, Hi-Tec, Adidas Golf, Nike (Nanalyze 2013)
Legacy: life sciences, filtration and energyLab consumables, filter makersPipette tips and filtration media (ICON deal release 2009)

Independent characterisation

P2i is best understood as a niche, IP-heavy, project-driven industrial-services company whose revenue tracks the product cycles of a small number of large electronics OEMs. Revenue has been volatile: indicative YoY swings of +65% (FY2016), −41% (FY2018), +38% (FY2022) and −1% (FY2023). The company is in transition from a single-technology plasma vendor dependent on smartphones toward a multi-technology (plasma plus LBC), multi-vertical supplier, with hearing aids, automotive and India as the stated growth vectors. The 2025 change of control to Jolt Capital, the 2026 management additions (a CCO hired from US rival actnano) and the 2026 capital reorganisation are consistent with a buy-and-build or scale-up thesis under new ownership.

Strategy

Stated strategic themes (paraphrased from company materials, 2025–2026)

  1. Dual-technology, full-stack protection partner. P2i presents plasma coating, liquid barrier coating, bespoke development and global manufacturing logistics "under one roof", which it claims no competitor offers (p2i.com 2026).

  2. Regulatory tailwind: PFAS-free, PFOA-free, solvent-free. Marketed as ahead of global regulatory direction, with a migration roadmap offered to customers (p2i.com; P2i 2025 review).

  3. Right-to-repair and circularity. Fully reworkable coatings that enable repair and battery replacement and reduce e-waste. This was a core thesis of the Circularity Capital (2021) and HSBC (2022) financings.

  4. Vertical diversification away from smartphones into hearing aids and medical devices, automotive and industrial IoT (p2i.com markets; 2025 review).

  5. Geographic expansion. Deepen India and enter new territories in 2026 (2025 review). PwC described the Jolt deal as enabling expansion into new markets and support for the investment needs of existing customers.

  6. Engineering-led selling. Direct access to the scientists who built the technology; the website promises a specialist response within 48 hours (p2i.com 2026).

Initiatives in the last 24 months

InitiativeDateDetailsSource
Jolt Capital controlling investment30 Sep 2025Initial €8m commitment; management co-invests; Jolt's first UK investmentP2i 2025 review; PwC
Liquid Barrier Coatings launch2,025Production-ready LBC range; coating recommended from customer test plans and CADP2i 2025 review
PFOA-free / PFAS-free hearing-aid push2025 (blog 10 Sep 2025)Targets EU PFOA exemption expiry for medical devicesP2i
India expansion2025–First customer partnership integrating coatings into productionP2i 2025 review
Leadership upgrade2,026CCO hired from actnano; Jolt partners on boardp2i.com
Brand / website relaunch2,026Repositioned from "liquid-repellent nanotechnology" to "molecular-level protective coatings at OEM scale"p2i.com vs legacy.p2i.com
Capital reorganisationNov 2025 – Jul 2026Share subdivision (21 Nov 2025); new articles and varied share rights (Jan 2026); capital reduction (Jul 2026)Companies House
Patent application: coating apparatusFiled 14 Aug 2023GB202312418 / WO2025036952PitchBook

Medium-term targets and guidance

No financial guidance is published (private company). An Oct 2025 P2i press release, as cited by TechSci Research, reportedly sized the addressable market for advanced protective nano-coatings at about €2bn by 2026.

Products & Services

Sources: p2i.com (2026) Solutions and Insights claims; P2i 2025 review; Dealroom; TechRadar; ICON 2009; Nanalyze 2013; Physics World 2014.

Product Portfolio

Product / brandTechnologyDescription & key capabilitiesTarget customersLaunch / latestPricing

Plasma Coating — Splash-proof (formerly Aridion)

Pulsed-plasma PECVD, hydrophobic

Invisible nano-film on internal and external surfaces; protects against everyday splashes and spills without affecting acoustic components or electrical contacts; reduces but may not fully eliminate masking. Company case study claims more than 90% fewer field failures in consumer electronics

Smartphone, wearable and hearing-aid OEMs

Aridion c. 2008; rebranded 2013; current

—

Plasma Coating — Barrier (incl. Dunkable®)

Pulsed-plasma PECVD, barrier conformal

Electrically insulating barrier for PCBA; designed for immersion-class protection (historically up to 30 minutes submerged per the 2014 Dunkable launch). Company case study: 99.995% first-pass yield and zero scrap at volume after replacing parylene (which had plateaued at ~3% scrap) in wireless earphones

Earphones, wearables, smartphones, IoT

Dunkable first on phones 2014; current

—

Liquid Barrier Coatings (LBC)

Liquid-applied ultra-thin barrier

Spray, dip or jet application into existing lines; no vacuum, no cure cycle, no new capital equipment; IPX3–IPX8; multi-substrate. P2i recommends a coating from the customer's qualification test plan and CAD/STEP files

Automotive, industrial, high-throughput electronics

Launched 2025

—

PFAS-free / PFOA-free coating variants

Plasma and LBC chemistries

Marketed as compliant alternatives as PFOA exemptions for medical devices entering the EU expire. Company claims about 50% fewer field-failure returns in hearing aids

Hearing-aid and medical OEMs

Long-established; promoted heavily 2025

—

Factory-in-factory deployment service

Equipment, process and support

Installation of P2i coating systems inside customer or EMS plants with continuous on-site support; chambers up to 2,000 L (about 600 phones per cycle)

High-volume OEMs / EMS

Since c. 2011 (Motorola)

—

Engineering & qualification services

Services

Sampling, concept-to-NPI-to-mass-production support, coating selection, reliability testing

All verticals

Ongoing

—

Bespoke / custom development

R&D services

Custom coating development for specific failure modes

All verticals

Ongoing

—

ion-mask™ (legacy)

Plasma, oleophobic / hydrophobic for textiles

Water- and oil-repellent finish for footwear and apparel

Timberland, Teva, Hi-Tec, Adidas Golf, Nike

c. 2008–2013; no longer promoted

—

Functional coatings from Surface Innovations (legacy / IP)

Plasma functional films

Antimicrobial, super-hydrophilic, protein-resistant, reactive and conducting layers

Life sciences, filtration

IP acquired 2010; commercial status unclear

—

Life-science consumables coating (legacy)

Hydrophobic plasma

Reduces reagent and sample loss on pipette tips and labware

Biotech equipment makers

c. 2009–2013

—

Filtration & energy coatings (legacy)

Hydrophobic / oleophobic

Positioned as alternative or enhancement to ePTFE membranes; air-permeable, water-repellent filters

Filter manufacturers

c. 2009–2014

—

“—” = not publicly disclosed.

Financial Narrative

Basis: UK GAAP statutory group accounts, years ending 31 December; GBP millions unless stated. FY2020–FY2022 P&L from Craft.co (sourced to filed accounts). FY2022–FY2023 balance sheet and FY2023 revenue from Endole (filed accounts).

Income statement

Notes.

  • EBITDA: D&A not disclosed in retrieved sources.

  • EPS: not meaningful or not disclosed for a private company with multiple share classes.

  • Dividends: none reported. The company was loss-making FY2020–FY2022, so dividends are inferred to be nil.

  • Tax line: the "income tax expense" figures in Craft are negative (i.e., credits). These are consistent with UK R&D tax credits, but that characterisation is an inference.

Margins and growth

Sources and derivations.

  • FY2020 growth of −14.5% is from Preqin's YoY series.

  • FY2021 growth (19.0%) matches both Preqin and Craft figures.

  • Margins are computed from Craft.co P&L lines.

  • Revenue per employee = revenue ÷ average headcount (Endole: 232 in FY2022; 203 in FY2023).

Revenue CAGR FY2020–FY2023: about 17.5% p.a. (from £14.7m to £23.87m).

Indicative longer revenue history (derived)

Preqin publishes only YoY growth rates. The absolute values below are back-calculated from Craft's FY2020 revenue of £14.7m. They are INDICATIVE, not filed figures.

The FY2016 growth of +65% is corroborated by P2i's own statement in May 2017 that revenue grew 65% YoY and the company turned profitable in 2016 (Electronic Specifier).

Source conflict. Preqin states FY2023 revenue of £29,696,324, whereas the Endole transcription of the filed FY2023 accounts gives £23.87m (down £277k YoY). The Endole figure is internally consistent with Craft's FY2022 figure of £24.15m and is preferred here. The Preqin figure is flagged as unreconciled; it may reflect a different entity scope or a data error. A third aggregator (globaldatabase) shows "£126M", which is clearly erroneous and has been disregarded.

Balance sheet

Sources and derivations.

  • FY2023 figures are from Endole (filed accounts).

  • FY2022 figures are derived by adding back Endole's stated YoY changes: total assets −£3.94m, cash −£108k, liabilities −£1.54m, net assets −£2.41m. The derived FY2022 cash of £3.87m agrees with Craft's £3.9m.

  • Context: £15m HSBC Growth Lending facility (Nov 2022); historical Clydesdale facilities (£5m 2014; £10m 2017). Drawn balances are not disclosed.

The fall in net assets of £2.41m in FY2023 suggests a further loss of roughly that size, absent equity movements.

Cash flow

Notes.

  • Equity raised FY2021: £8m from Circularity Capital, announced 13 Dec 2021.

  • Debt facility FY2022: £15m HSBC UK Growth Lending, 28 Nov 2022.

Commentary on trends, inflections and drivers

FY2020–FY2021 (deep losses).

  • Revenue fell to £14.7m in FY2020 amid the pandemic and a weak smartphone cycle.

  • Operating losses of £7.0m (FY2020) and £8.7m (FY2021) reflect a cost base of £15.7–17.0m that was far larger than gross profit.

  • FY2021 gross margin compressed to 47.1%. Cost of sales rose from £6.0m to £9.3m while revenue grew only 19%. This is consistent with equipment deployment or start-up costs on new programmes, but the driver is not disclosed.

  • The leadership change in 2021 (Saunders as Executive Chairman) and the £8m Circularity equity injection in Dec 2021 point to a recapitalisation and turnaround.

FY2022 (inflection).

  • Revenue rose 38% to £24.15m.

  • Gross margin expanded to 68.1% on lower absolute cost of sales (£7.7m).

  • EBIT losses narrowed to −£1.3m, with opex held at £17.7m.

  • This is the clearest operating inflection in the dataset and coincided with the £15m HSBC facility, which was explicitly intended to fund international expansion.

FY2023 (stall).

  • Revenue was flat at £23.87m (−1.2%).

  • Headcount was cut 13% (from 232 to 203).

  • Net assets fell 38% to £3.93m and leverage (liabilities/assets) rose to 81%.

  • The balance sheet was thin relative to a £15m debt line, which helps explain the 2025 sale of control to Jolt and the "financial strength at a pivotal time" language in P2i's 2025 review.

Signals:

  • The 18 Aug 2026 satisfaction of charge 048143500014 may indicate a refinancing or repayment of a secured lender facility after the Jolt equity. The lender is not identified in sources retrieved.

  • The July 2026 capital reduction to £1,000 of issued share capital, backed by a directors' solvency statement, is typically used to create distributable reserves or simplify the capital structure post-acquisition.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRoleStatus / notesSource

P2I Holdings Ltd (16653813)

Holding company (SIC 64202) and PSC of P2i Ltd

Incorporated 15 Aug 2025; first accounts due 30 Sep 2026; Jolt vehicle

Companies House

P2i Ltd (04814350)

Group parent and UK operating company

Files group accounts

Companies House

Surface Innovations Limited

Wholly owned subsidiary (functional-coating IP)

Active; acquired Jul 2010

Endole; P2i release 2010

P2i Inc. (USA)

US subsidiary

A "President, P2i Inc" role has been listed since Mar 2009

Endole team listing

China operating entity (Shenzhen)

Applications / production-support centre

Entity name not disclosed; address in Hengchangrong High-Tech Industrial Park, Xixiang, Bao'an, Shenzhen

Craft.co locations

Revenue by Segment and Segment Margins & Growth (%)

Segment / vertical (GBP Mn)FY2021FY2022FY2023

Total group revenue (GBP Mn)

17.524.1523.87

Total revenue YoY growth (%)

19.038.0-1.2

Income Statement

MetricFY2020FY2021FY2022FY2023

Revenue (GBP Mn)

14.717.524.1523.87

Cost of sales (GBP Mn)

6.09.37.7—

Gross profit (GBP Mn)

8.78.216.5—

General & administrative expense (GBP Mn)

10.910.210.5—

Total operating expenses (GBP Mn)

15.717.017.7—

Operating income / EBIT (GBP Mn)

-7.0-8.7-1.3—

Interest expense (GBP Mn)

1.10.6380.667—

Pre-tax income (GBP Mn)

-8.1-9.4-2.0—

Income tax credit (GBP Mn)

0.4291.10.461—

Net income (GBP Mn)

-7.7-8.3-1.5—

Dividends per share (GBP)

000—

Margin Analysis (%) and Income Statement

MetricFY2020FY2021FY2022FY2023

Revenue growth YoY (%)

-14.519.038.0-1.2

Gross margin (%)

58.947.168.1—

Operating (EBIT) margin (%)

-47.6-49.8-5.4—

Pre-tax margin (%)

-55.1-53.7-8.3—

Net margin (%)

-52.4-47.4-6.2—

Revenue per employee (GBP K)

——104118

Income Statement and Margin Analysis (%)

MetricFY2016FY2017FY2018FY2019FY2020

Revenue, derived from Preqin YoY rates (GBP Mn, indicative)

18.323.113.617.214.7

Revenue growth YoY per Preqin (%)

65.426.7-41.326.6-14.5

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Balance Sheet and Margin Analysis (%)

MetricFY2022FY2023

Total assets (GBP Mn)

24.2820.34

Cash & equivalents (GBP Mn)

3.873.76

Total liabilities (GBP Mn)

17.9616.42

Net assets / equity (GBP Mn)

6.343.93

Liabilities to assets (%)

7481

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Balance Sheet

MetricFY2020FY2021FY2022

Dividends paid (GBP Mn)

000

Share buybacks (GBP Mn)

000

Equity raised (GBP Mn)

—8.0—

Debt facility arranged (GBP Mn)

——15.0

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2020FY2021FY2022FY2023

ROE on year-end equity (%)

——-23.7—

ROA on year-end assets (%)

——-6.2—

Interest coverage EBIT to interest (x)

-6.4-13.6-1.9—

Asset turnover (x)

——0.991.17

Revenue by Region

Region (GBP Mn)FY2021FY2022FY2023

Total revenue (GBP Mn)

17.524.1523.87

Marker Details

MarkerValueDateSource

Dealroom enterprise-value estimate (stale)

€26–40m

Jun 2010

startups.one.gob.es (Dealroom data)

Jolt controlling investment

Initial €8m (≈US$9.39m)

30 Sep 2025

PwC; CB Insights

Caplight secondary-market activity

Momentum score "Top 50%"; pricing gated

2026

Caplight

Listed peer reference: Favored Nanotechnology market cap

CNY 10.80bn (≈US$1.60bn)

12 Aug 2026

Disfold

Listed peer reference: Favored price / sales (indicative)

≈21.6x (CNY 10.8bn / CNY 499.4m TTM)

Aug 2026

Analyst calculation from Disfold

Balance Sheet (2009–2025)

Metric2009201020142017202120222025

Equity raised (GBP Mn)

4.15.5——8.0——

Debt facilities arranged (GBP Mn)

——5.010.0—15.0—

Sponsor equity committed (EUR Mn)

——————8.0

Analyst Conclusions

Management guidance

No numerical guidance has been published. Qualitative 2026 priorities (P2i 2025 review; p2i.com) are:

  • become further established in India;

  • enter new territories;

  • strengthen position across global markets;

  • scale LBC alongside plasma;

  • lead customers through PFAS / PFOA transitions, especially in hearing aids and medical devices.

Consensus

No sell-side coverage or consensus exists (private company).

Bull case

  1. Operating leverage is proven. In FY2022 a 38% revenue increase took EBIT from −£8.7m to −£1.3m on a roughly flat cost base (£17.0m to £17.7m opex). Revenue growth into the high-£20m range could tip the business into sustained profitability.

  2. Regulation is a forcing function. PFOA exemptions for EU medical devices are ending, and P2i has long-established PFAS-free coatings plus more than 100m hearing aids already protected. That gives it an incumbency-plus-compliance advantage in a sticky, quality-driven niche.

  3. The sponsor and team upgrade change the trajectory. Jolt brings capital (Fund V first close near US$1bn), semiconductor-industry operators on the board, and M&A capability. Hiring actnano's former CTO adds credibility in liquid barriers for automotive, where capex-free LBC lowers adoption friction.

Bear case

  1. The IP moat has eroded. Disclosed patents fell from more than 175 granted (2014) to 24 granted or pending (2026). US enforcement against Favored failed, culminating in a 2026 attorneys' fee award with a bad-faith finding, and the '087 patent faces an instituted IPR.

  2. Sub-scale against a funded Chinese rival. Favored generates about 2x P2i's revenue with about 5x the headcount, has public-market capital, and has its home market where most consumer-electronics assembly happens.

  3. The financial record is weak and opaque. Revenue stalled in FY2023 (−1.2%), net assets fell 38% to £3.93m, and leverage reached 81% of assets. FY2024–FY2025 results are not public, and the July 2026 capital reduction and sponsor control further limit visibility.

Catalysts and monitorables (next 12 months)

  • FY2025 statutory accounts for P2i Ltd and the first P2I Holdings Ltd consolidated accounts (due 30 Sep 2026): revenue trend, EBITDA, debt, R&D spend and auditor's going-concern statement.

  • Quantum of the N.D. Cal. attorneys' fee award and any appeal; outcome of IPR2024-00380.

  • Named LBC design wins in automotive or industrial markets.

  • Scale-up of the India customer and any new-country entries.

  • Any Jolt-led bolt-on acquisition (an actnano link is UNCONFIRMED and unevidenced).

  • New charges registered (refinancing) following the Aug 2026 charge satisfaction.

  • Hearing-aid OEM transitions timed to EU PFAS / PFOA deadlines.

Concluding analyst verdict

P2i is a genuine technology pioneer whose commercial story has never matched its scientific promise. It was spun out of the UK Ministry of Defence in 2004. It took plasma nano-coating from a Durham PhD into Motorola's handset lines and, by its own count, has protected more than a billion devices, and more than 100 million hearing aids. Yet the filed numbers describe a £24m-revenue business that lost money in every year we can verify (FY2020–FY2022). Its revenue has swung by tens of percent on customer cycles, and by FY2023 its equity cushion was below £4m.

The investment case has reset with Jolt Capital's control in September 2025, and three changes matter.

Capital: The sponsor's equity and the subsequent satisfaction of a secured charge appear to have repaired the balance sheet, although FY2024–FY2025 figures remain unseen.

Portfolio: Adding Liquid Barrier Coatings turns P2i from a capex-heavy plasma vendor into a two-platform supplier that can win automotive and industrial programmes without asking customers to buy vacuum chambers.

Positioning: P2i is reframing itself around PFAS-free, reworkable chemistry just as EU regulation forces medical-device makers to change.

Against this stand serious weaknesses. P2i's patent estate has shrunk dramatically. Its attempt to enforce US patents against its larger Chinese rival Favored ended in dismissal and a 2026 fee award for bad-faith conduct. In smartphones and earphones, Favored's scale, listing and home-market proximity make P2i the challenger, not the leader.

Our verdict: a credible but unproven sponsor-backed turnaround. The upside rests on medical and hearing-aid regulatory tailwinds and LBC traction in automotive, where P2i's reliability engineering and chemistry credentials matter more than unit cost. The key test is the FY2025 accounts. Sustained revenue above £25m with positive EBITDA would validate the thesis; another flat year would confirm a niche, sub-scale player best suited to consolidation.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenurePrior rolesEducationAge (from Companies House DOB)

Chris Saunders

Chief Executive Officer; director; company secretary

Joined 2021 as Executive Chairman; director since 10 Sep 2021; secretary since 24 Mar 2022; described as "CEO & Chair" in Oct 2025, CEO only in 2026

Executive Chairman, i2O Water (exit to Mueller Water Products, 2021); co-founder, Navetas Energy Management (exit 2017); Divisional MD, Actaris (€1.8bn trade sale); VP and President, BEAMA

—

~56 (born Jun 1970)

Ahilan Rabindran

Chief Financial Officer; director

Joined 2016; director since 24 Mar 2022

IMImobile (2014 IPO team); SSE plc

FCA Chartered Accountant

~43 (born Nov 1982)

Dr Stephen Coulson

Chief Technology Officer; founder

Since 2004; board director 2 Feb 2004 – 30 Sep 2025

Dstl / MoD (scaled the patented technology)

PhD, Durham University

~51 (born Nov 1974)

Dr Justin Kleingartner

Chief Commercial Officer

Appointed 2026 (exact date not disclosed)

CTO, actnano; earlier at LiquiGlide (MIT spin-out)

PhD and MS ChemE Practice (MIT); BS ChemE (Iowa State)

—

Martin Tolliday

Chief Operating Officer

Previously Chief Product Officer; board director until 30 Sep 2025

25+ years in automotive, motorsport and defence

Automotive Technology

—

Jing Yan

General Manager, China

Since 2023

Huawei; 15+ years in consumer devices (R&D, NPI, mass production)

EE, Xi'an Jiaotong University

—

Theresa Marks

People & HR

Since 2022

Own HR practice (Add HR); consultancy and global tech

Chartered MCIPD

—

“—” = not publicly disclosed.

Board of Directors

NameRoleAppointedAffiliationIndependence

Pierre Garnier

Chairman (per p2i.com)

30 Sep 2025

Managing Partner, Jolt Capital. Formerly President of e2v semiconductors (sold to Teledyne 2017), COO of Inside Secure, VP & GM at Texas Instruments. Supélec engineering degree

Investor nominee (non-independent)

Marie Nicod

Non-Executive Director

30 Sep 2025

General Partner, Jolt Capital. Formerly at Naval Group, Thales and Aresia. École des Ponts ParisTech / ENSTA

Investor nominee

Chris Saunders

Executive director (CEO)

10 Sep 2021

Management

Executive

Ahilan Rabindran

Executive director (CFO)

24 Mar 2022

Management

Executive

Andrea Traversone

Board Observer / Strategic Advisor (not a statutory director)

2025/26

Managing Partner, Jolt Capital; founding Managing Partner of the NATO Innovation Fund; ex-Amadeus Capital

Investor representative

Board & Management Changes

DateChange

23 Apr 2025

Andrew Henry Lane resigned (director 2015–2016 and 2018–2025)

29 Jul 2025

Panayotis Malliris (ADV Partners, Hong Kong) resigned (director since Sep 2015)

1 Aug 2025

Bradley Dean Landes (ADV Partners) resigned (director since Jan 2019)

30 Sep 2025

Resigned: Stephen Coulson, Stephen Brooke (Ombu; since 2017), Ian Nolan (Circularity Capital; since Nov 2021), Martin Tolliday. Appointed: Pierre Garnier, Marie Nicod

Major Shareholders

HolderStakeNotes

P2I Holdings Ltd (Jolt Capital-controlled)

Controlling (PSC; exact % not disclosed)

From 30 Sep 2025

Management

Co-investment ("management participation"); % not disclosed

PwC Deals; P2i

Former PSCs: ADV Opportunities Fund I L.P.; Ombu

Ceased 30 Sep 2025

Companies House

Competitive Landscape

Key Competitors

#CompetitorHQOwnershipTechnologyOverlap with P2iScale indicator
1

Jiangsu Favored Nanotechnology (Favored Tech)

Wuxi, China

Listed, Shanghai STAR (688371), IPO Aug 2022

PECVD nano-coatings for phones, wearables, audio, automotive

Most direct: same process class; litigation adversary; Chinese OEM base

Revenue CNY 500.2m (TTM to 30 Sep 2025); ~1,075 employees; market cap CNY 10.8bn (12 Aug 2026) (Simply Wall St; Disfold)

2

HZO Inc.

USA

Private

Parylene, plasma and ALD-type nano-coatings for electronics

Direct in consumer electronics

Revenue not disclosed

3

actnano

Cambridge, MA, USA

VC-backed (raised $40m Apr 2024)

PFAS-free ultra-thin liquid conformal coatings

Direct in automotive / consumer; P2i hired its former CTO

Revenue not disclosed

4

Europlasma

Oudenaarde, Belgium

Private

Low-pressure plasma nano-coatings

Direct plasma rival

Revenue not disclosed

5

Auland

China

Private

Vacuum coating equipment and nano-coatings for consumer electronics

Direct in China

Revenue not disclosed

6

Diamond-MT

USA

Private

Parylene, liquid, plasma, ALD and multilayer coating services

Parylene / service alternative

Revenue not disclosed

7

Liquipel

USA

Private

Nano-coating for consumer devices

Consumer electronics

Revenue not disclosed

8

NanoFlowX

Texas, USA

Private

Two-step nano-coatings for PCBs

Low-end PCB protection

Revenue not disclosed

9

Coat-X

Switzerland

Acquired 2024 by a French corporation

Multilayer barrier coatings (medical / hearables)

Medical / hearables

Revenue not disclosed

10

NBD Nano; Cytonix; Naco Technologies

US / Latvia

Private / formerly VC-backed

Hydrophobic / oleophobic surface coatings

Niche

Revenue not disclosed

11

Traditional conformal-coating suppliers (e.g., HumiSeal / Chase, Electrolube, silicone and acrylic coating majors)

Global

Various

Acrylic, silicone, urethane, epoxy conformal coatings

Substitute technology in automotive / industrial PCBA

Large; not benchmarked

Peer Comparison FY2023

MetricP2i (FY2023)Favored Nanotech (TTM Sep 2025)

Revenue (local)

GBP 23.87m

CNY 500.2m (≈GBP 52m at ~9.6 CNY/GBP, indicative)

Revenue growth

-1.2% (FY2023)

Quarterly YoY -28.4% (latest quarter, Disfold)

Gross margin

68.1% (FY2022)

≈53.9% (269.4 / 500.2)

Net margin

-6.2% (FY2022)

≈9.4% (46.9 / 500.2)

Employees

203

~1,075

Recent Developments

The FY2023 headcount reduction from 232 to 203 predates it.

Company Snapshot

$29.7M

Revenue

203

Employees

$9.4M

Market Cap

2004

Founded

Abingdon, United Kingdom

Headquarters

SWOT Analysis

Strengths

  • High gross margin. 68.1% in FY2022 (£16.5m gross profit on £24.15m revenue; Craft.co / filed accounts), indicating pricing power in a service-plus-IP model.
  • Long mass-production record. Plasma machines on Motorola lines in 2011–2014; more than 175m smartphones coated by 2017; more than 700m devices by Dec 2021; more than 1bn by Dec 2025 (Physics World; Electronic Specifier; P2i).
  • Hearing-aid incumbency. More than 100m hearing aids protected (p2i.com 2026), up from more than 5m in 2013 (Nanalyze).
  • Two-platform portfolio. Plasma plus LBC (launched 2025), which the company claims is unique at OEM scale (p2i.com).
  • Regulatory-aligned chemistry. PFAS-free, solvent-free and fully reworkable (p2i.com 2026), matching EU PFAS and right-to-repair trends.
  • Committed deeptech sponsor. Jolt Capital took control in Sep 2025 with an initial €8m; its new fund reached a first close near US$1bn in Nov 2025 (PwC; The Logic).
  • Founder-scientist retained. The inventor (Coulson) remains CTO and is now joined by an MIT-PhD CCO with liquid-barrier expertise (p2i.com).

Weaknesses

  • Chronic losses. EBIT of −£7.0m (FY2020), −£8.7m (FY2021) and −£1.3m (FY2022); pre-tax loss of £2.0m in FY2022 (Craft.co).
  • Thin, leveraged balance sheet. Net assets fell 38% to £3.93m and liabilities reached 81% of assets in FY2023 (Endole).
  • Revenue volatility. Indicative swings of −41% (FY2018) and +38% (FY2022) (Preqin; Craft), reflecting design-win dependency.
  • Shrinking IP estate. From more than 175 granted patents (2014) to 24 granted or pending (2026) (P2i releases; p2i.com).
  • Sub-scale versus main rival. FY2023 revenue of £23.87m against Favored's CNY 500m TTM (≈£52m indicative) and ~1,075 employees.

Opportunities

  • EU PFOA / PFAS deadlines for medical devices driving hearing-aid OEMs to compliant coatings (P2i 2025 review).
  • Automotive and industrial PCBA via LBC, which needs no new capital equipment at the customer and slots into existing spray or dip lines (p2i.com).
  • India manufacturing growth. First customer partnership in 2025 is described as encouraging (P2i 2025 review).
  • Parylene displacement. Claimed 99.995% first-pass yield and zero scrap versus a 3% parylene scrap plateau in earphones (p2i.com Insights).
  • Buy-and-build under Jolt. The sponsor has a portfolio and M&A programme (Jolt UK MD's remit includes portfolio M&A; Private Equity Wire).
  • Conformal-coating market growth of about 5–8% CAGR (Fortune BI; TechSci; Grand View), with Asia-Pacific representing about 86% of consumption.

Threats

  • Favored Nanotechnology. A listed Chinese PECVD competitor with IPO capital (≈US$230m raised, 2022; CB Insights) and an entrenched domestic OEM base.
  • Adverse IP outcomes. US claims dismissed (Sep 2024); appeal dismissed (Jul 2025); attorneys' fees awarded against P2i for bad-faith conduct (Mar 2026; Bloomberg Law).
  • Ongoing PTAB challenge. IPR2024-00380 against the '087 patent was instituted (Patexia), threatening remaining US coverage.
  • Substitution by mechanical sealing. Smartphone OEMs increasingly use IP68 gasket designs (industry trend; P2i's own 2014 commentary acknowledged gasket and membrane alternatives).
  • Customer concentration and pricing pressure in China-based EMS supply chains (inference from geographic profile).
  • Competition from well-funded US rivals, e.g., actnano raising $40m in 2024 (CB Insights).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
23 Apr 2025NED Andrew Lane resigns Companies HouseStart of board turnover ahead of sale
16 Jun 2025P2i appeal docketed at Federal Circuit (No. 25-1865) vs Jiangsu Favored PatSnapContinuation of IP enforcement
18 Jul 2025Fed. Cir. dismisses P2i appeal for failure to pay fees / file appearance PatSnapProcedural setback; signals reduced litigation appetite or funding
29 Jul 2025ADV Partners director Malliris resigns Companies HousePre-exit of Asian PE shareholder
1 Aug 2025ADV Partners director Landes resigns Companies HouseAs above
15 Aug 2025P2I Holdings Ltd incorporated Companies HouseAcquisition vehicle for Jolt
10 Sep 2025Company publishes PFOA-free hearing-aid coating positioning P2i blogRegulatory-driven demand in medical
30 Sep 2025Jolt Capital completes controlling investment; ADV and Ombu cease as PSCs Companies House; P2iChange of control; recapitalisation
30 Sep 2025Board reconstituted: Garnier and Nicod appointed; Coulson, Brooke, Nolan, Tolliday step off Companies HouseInvestor-controlled board
30 Sep 2025Share subdivision of M, N ordinary and deferred shares (resolution filed 10 Oct 2025) Companies HouseCapital restructuring
2 Oct 2025Deal recorded by data providers (≈US$9.39m) CB Insights; CaplightMarket visibility
Oct 2025PwC South East announces sell-side advisory role; Saunders (CEO & Chair) thanks PwCConfirms deal structure (control plus management participation)
Oct 2025P2i release reportedly sizes the protective nano-coating addressable market at about €2bn by 2026 TechSci (secondary)Market framing for investors
13 Nov 2025FY2024 group accounts filed (40 pages) Companies House–
21 Nov 2025Further share subdivision Companies HousePost-deal capital structuring
27 Nov 2025Jolt Capital's Fund V reaches first close near US$1bn The LogicSponsor firepower for follow-on investment
15 Dec 20252025 roundup: Jolt control, LBC launch, PFAS-free hearing aids, India partnership; more than 1bn devices protected P2i (legacy site)Strategic narrative for 2026
2025 (date n/d)Liquid Barrier Coatings range launched P2iSecond technology platform; no capex needed by customers
31 Jan 2026New Articles; variation of share rights; share-class renaming Companies HousePost-deal governance
10 Feb 2026SH02 (sub-division) filed Companies HouseCapital administration
31 Mar 2026N.D. Cal. grants Favored and GN Audio attorneys' fees, finding P2i engaged in bad-faith litigation conduct Bloomberg LawMaterial adverse legal / financial and reputational event; fee quantum not disclosed
2026 (date n/d)Website relaunch; "10B+ devices protected" claim; 24 patents granted / pending p2i.comRepositioning; IP count disclosure
2026 (date n/d)Justin Kleingartner (ex-actnano CTO) named CCO p2i.comTalent acquisition from direct competitor; LBC credibility
2026 (date n/d)Pierre Garnier named Chairman; Andrea Traversone named board observer / strategic advisor p2i.comSponsor governance
21 May 2026Confirmation statement (with updates); statutory registers moved to registered office Companies HouseRoutine; shareholder changes
2 Jul 2026Special resolution to reduce share capital, with directors' solvency statement Companies HouseCreates distributable reserves / simplifies capital
10 Jul 2026Statement of capital: £1,000 Companies HouseCompletion of reduction
14 Jul 2026CS01 filed Companies HouseRoutine
18 Aug 2026Charge 048143500014 satisfied in full Companies HouseLikely repayment / refinancing of a secured facility (lender not identified)
30 Sep 2026Deadline for FY2025 accounts (P2i Ltd and P2I Holdings Ltd) Companies House–

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Income Statement: Revenue & Gross Profit: Revenue rose from GBP 14.7 Mn in FY2020 to GBP 23.9 Mn in FY2023.
P2i Ltd. — Income Statement: Revenue & Gross Profit
Series (GBP Mn)FY2020FY2021FY2022FY2023
Revenue14.717.524.223.9
Cost of sales69.37.7—
Gross profit8.78.216.5—

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Companies House, P2I LTD overview (find-and-update.company-information.service.gov.uk)
  2. Companies House, officers (find-and-update.company-information.service.gov.uk)
  3. Companies House, filing history (find-and-update.company-information.service.gov.uk)
  4. Companies House, P2I Holdings Ltd (find-and-update.company-information.service.gov.uk)
  5. P2i website (2026): and: p2i.com · p2i.com
  6. P2i 2025 Roundup (15 Dec 2025) (legacy.p2i.com)
  7. P2i investors page (legacy) (legacy.p2i.com)
  8. P2i company overview (legacy) (legacy.p2i.com)
  9. P2i legal action vs Favored (2019) (p2i.com)
  10. PwC Deals, P2i / Jolt Capital (Oct 2025) (pwc.co.uk)
  11. UKTN, HSBC £15m (Nov 2022) (uktech.news)
  12. New Electronics, Circularity Capital £8m (Dec 2021) (newelectronics.co.uk)
  13. Electronic Specifier, £10m Clydesdale/Yorkshire Bank (2017) (electronicspecifier.com)
  14. ICON Corporate Finance, 2009 and 2010 rounds: and: iconcorpfin.com · iconcorpfin.com
  15. PR Newswire, 10th anniversary (Jan 2014) (prnewswire.co.uk)
  16. Textile World, Surface Innovations acquisition (2010) (textileworld.com)
  17. Physics World (2014) (physicsworld.com)
  18. Craft.co financials (craft.co)
  19. Endole (open.endole.co.uk)
  20. Preqin (preqin.com)
  21. PitchBook (pitchbook.com)
  22. CB Insights (cbinsights.com)
  23. Caplight (caplight.com)
  24. Bloomberg Law, fees order (31 Mar 2026) (news.bloomberglaw.com)
  25. Bloomberg Law, MTD order (Sep 2024) (news.bloomberglaw.com)
  26. P2i Ltd v. Favored Tech USA (Westlaw copy) (finnegan.com)
  27. PatSnap, Fed. Cir. 25-1865 (patsnap.com)
  28. Patexia, IPR2020-00478 and IPR2024-00380: and: services.patexia.com · services.patexia.com
  29. Simply Wall St, Favored (688371) (simplywall.st)
  30. Disfold, Favored (disfold.com)
  31. The Logic, Jolt Fund V (Nov 2025) (thelogic.co)
  32. Fortune Business Insights, conformal coatings (fortunebusinessinsights.com)
  33. TechSci via GII, conformal coating (giiresearch.com)
  34. BCC Research, conformal coatings in electronics (bccresearch.com)
  35. IMARC, conformal coatings (imarcgroup.com)
  36. Nanalyze (2013) (nanalyze.com)
  37. GSMArena (2013) (m.gsmarena.com)
  38. Wikipedia, P2i (en.wikipedia.org)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.